公司資料
uniQure N.V. 股價、新聞與催化劑
- 股票代碼:
- QURE
- 交易所:
- NASDAQ
- 產業:
- Biopharma
- 所在地:
- Netherlands
股票表現
44.31 USD (+0.70%)
收盤價
最後更新: 2026年9月21日
1.69B USD
市值
股價為何變動
截至 2026年9月21日，QURE 上漲 0.70%，收於 $44.31。目前新聞監測窗口內未發現新的同公司新聞。
公司概覽
業務概覽
uniQure is a gene-therapy company focused on rare diseases and neurological disorders. Its platform and clinical programs make it one of the better-known names in viral-vector gene therapy.
所在地與產業分類
Headquartered in the Netherlands and listed on NASDAQ as an ADR, uniQure has a global gene-therapy footprint.
商業模式特徵
The business is driven by clinical data, manufacturing capability, and the challenge of turning gene therapy into durable value.
生技產業定位
uniQure is a classic gene-therapy catalyst name whose valuation is highly sensitive to program and safety outcomes.
未來催化劑
- uniQure's catalysts are AMT-130 in Huntington's disease and the rest of its gene-therapy pipeline, where any clean clinical or regulatory step can matter a lot. The company still needs the next update to show the gene-therapy platform can keep building beyond a single program.
近期新聞
新聞標題由機器翻譯，詳情為英文原文。
- 01
- 02
- 03
- 04
- 05
相似股票
商業成熟度、治療領域或催化劑模式相近的同業公司。